Wills
1990
Clinical pharmacokinetics of interferons
Stoner et al.
1989
The effects of single L-amino acid substitutions on the lethal potencies of the microcystins
Pestka et al.
1981
[1] Definition and classification of the interferons
CZ305123B6
(cs )
2015-05-13
Způsob výroby kapalného farmaceutického prostředku
DE1511719U
(enExample )
EP2853535B1
(en )
2019-12-25
Biologically active peptide complexes
ATE178975T1
(de )
1999-04-15
Hochdruckpumpe zur flüssigkeits-feindosierung
EP0314011A3
(de )
1990-04-11
Purinderivate
Keilholz et al.
2000
The emerging role of cytokines in the treatment of advanced melanoma
RU2470031C2
(ru )
2012-12-20
Биологически активные пептидные комплексы
MIRZAYEVA
2025
“DEVONU LUG ‘ATIT TURK” ASARIDAGI KIYIM-KECHAK NOMLARINING DIAXRON VA SINXRON TUZILISHI
DE69327310D1
(de )
2000-01-20
Amadori-reaktion-verbindungen, und -produkte, verfahren zu deren herstellung und deren verwendung
Carson et al.
1942
Self-incompatibility in certain diploid potato species
US2234981A
(en )
1941-03-18
Formaldehyde sulphoxylate derivatives of diphenyl-sulphides,-disulphides, -sulphoxides, and -sulphones, and methods of production
DE69002275T2
(de )
1993-11-04
Stabilisierung von organischen verbindungen.
Refai et al.
1970
Laboratory acquired infection with Keratinomyces ajelloi
GB923398A
(en )
1963-04-10
Diphenyl mono-and bis-formyl guanylhydrazones
EP1285663B1
(en )
2008-07-30
Protective interferon-beta against reinfection after liver transplantation
DE1782129U
(de )
1959-01-29
Nachtriegel.
DE1365851U
(enExample )
DE1495157U
(enExample )
GB1415333A
(en )
1975-11-26
Insulin derivatives
DE1507202U
(enExample )
WO1985000518A1
(en )
1985-02-14
Amplification of antibiotic and/or antitumour activity
DE1443548U
(enExample )